CINECA IRIS Institutional Research Information System

YOUNES, Ramy
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.286
AS - Asia 3.590
EU - Europa 2.489
SA - Sud America 244
OC - Oceania 78
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.918
CN - Cina 2.123
IT - Italia 584
SG - Singapore 291
CA - Canada 287
JP - Giappone 261
DE - Germania 247
SE - Svezia 235
GB - Regno Unito 230
IN - India 204
IE - Irlanda 193
FR - Francia 182
ES - Italia 158
BR - Brasile 144
KR - Corea 111
TW - Taiwan 109
UA - Ucraina 108
HK - Hong Kong 103
MX - Messico 77
VN - Vietnam 76
AU - Australia 73
GR - Grecia 72
ID - Indonesia 69
AT - Austria 63
TR - Turchia 63
PL - Polonia 54
FI - Finlandia 47
NL - Olanda 45
BE - Belgio 40
EG - Egitto 39
RU - Federazione Russa 39
DK - Danimarca 38
IR - Iran 36
CH - Svizzera 31
PT - Portogallo 28
CO - Colombia 26
AR - Argentina 25
IL - Israele 25
SA - Arabia Saudita 24
TH - Thailandia 23
RO - Romania 22
CL - Cile 21
PE - Perù 18
PH - Filippine 18
BG - Bulgaria 14
NO - Norvegia 11
CZ - Repubblica Ceca 9
HU - Ungheria 9
MY - Malesia 9
HR - Croazia 8
EC - Ecuador 7
MO - Macao, regione amministrativa speciale della Cina 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
CV - Capo Verde 6
JO - Giordania 6
EU - Europa 5
KE - Kenya 5
LB - Libano 5
LT - Lituania 5
NZ - Nuova Zelanda 5
IQ - Iraq 4
MA - Marocco 4
BY - Bielorussia 3
MK - Macedonia 3
RS - Serbia 3
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
HN - Honduras 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
Totale 10.754
Salva come PNG Salva come JPEG
Città #
Chandler 386
Beijing 326
Redwood City 253
Ann Arbor 247
Fairfield 245
Shanghai 237
Singapore 233
Ottawa 198
Dublin 188
Santa Clara 175
Ashburn 153
Guangzhou 142
Houston 122
Woodbridge 110
Torino 105
Hangzhou 104
Seattle 102
Wilmington 96
Dearborn 92
Wuhan 85
Nanjing 82
Jacksonville 69
Medford 64
Tokyo 61
Cambridge 60
Chengdu 55
New York 55
Princeton 53
Columbus 52
Taipei 52
Dong Ket 51
Pisa 50
Vienna 48
Turin 47
Jakarta 46
London 45
Nyköping 43
Chongqing 42
Seoul 35
Villeurbanne 33
Fremont 32
Zhengzhou 32
Sydney 31
Central District 30
Changsha 30
Tianjin 30
Hefei 29
Boston 28
Changchun 28
Athens 26
Barcelona 26
Jinan 26
Shenyang 26
Rome 23
San Diego 23
Toronto 23
Duncan 22
Helsinki 22
Kolkata 22
São Paulo 22
Chennai 21
Milan 21
Washington 21
Los Angeles 20
San Mateo 20
Brussels 19
Santiago 19
Warsaw 19
Istanbul 18
Madrid 18
Norwalk 16
Paris 16
Redmond 16
Rio de Janeiro 16
Rochester 16
Lima 15
Copenhagen 14
Amsterdam 13
Cairo 13
Delhi 13
Fortaleza 13
Jeddah 13
Manchester 13
Naples 13
Zhangjiagang 13
Boardman 12
Central 12
Falls Church 12
San Jose 12
Stockholm 12
Bangkok 11
Buenos Aires 11
Düsseldorf 11
Harbin 11
Nanchang 11
Salvador 11
Wenzhou 11
Atlanta 10
Frankfurt am Main 10
Fuzhou 10
Totale 5.749
Salva come PNG Salva come JPEG
Nome #
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation 1.457
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults 1.289
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 1.074
NASH in lean individuals 912
A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD 555
Should we undertake surveillance for HCC in patients with NAFLD? 543
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study 537
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease 268
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 221
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease 190
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 180
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study 174
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease 167
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 165
Risk factors for metabolic syndrome after liver transplantation: what has changed over time 138
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease 136
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 134
Microangiopathic hemolytic anemia caused by a signet-ring cell carcinoma of the intrahepatic bile duct 132
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 121
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD 115
The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality 112
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 111
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease 110
Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy 105
Prevalence of patients with non-alcoholic fatty liver disease: from primary care to tertiary centers. The Turin experience 105
Risk factors for arterial hypertension after liver transplantation 104
Comment on helicobacter pylori eradication using metronidazole 102
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease 99
Integrative hepatic transcriptome analysis identifies biomarkers of non-alcoholic steatohepatitis activity and fibrosis progression 98
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 97
Increased Pre-Hepatic Insulin Levels Are Directly Related to Nash, Fibrogenesis and Fibrosis in Non Diabetic NAFLD Patients but Not in Type 2 Diabetes 96
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients 93
Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin 91
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non- Alcoholic Fatty Liver Disease. a Longitudinal International Study. 91
Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease 90
NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2 alpha 90
Metabolic Syndrome after liver transplantation: have risk factors changed over time? 88
Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV patients 88
Risk of developing hepatocellular carcinoma in patients with cirrhosis of viral etiology evaluated by the combination of alphafetoprotein, protein induced by vitamin K absence or antagonist-II and glypican-3 85
Epidemiology and Natural History of Patients with NAFLD 84
Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma 82
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease 77
Is vitamin B12 serum level involved in the spread of Helicobacter pylori? 63
Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3) 61
Ductular reaction predicts the progression of non-alcoholic fatty liver disease 59
Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 47
Molecular mechanisms of hepatic fibrosis in chronic liver diseases 45
The long-term impact of baseline PNPLA3 genotyping in patients with NAFLD. A longitudinal multicentre study 43
Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease 42
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 34
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease 10
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis 9
CARATTERISTICHE CLINICHE E VARIANTI GENETICHE DEI PAZIENTI CON STEATOEPATITE NON ALCOLICA E BMI INFERIORE A 25 (“LEAN NASH”) 8
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis 7
Totale 11.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.589
article - articoli 0
book - libri 0
conference - conferenze 6.853
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020762 0 0 0 0 0 0 112 116 155 173 119 87
2020/20211.976 101 131 113 135 166 159 187 177 211 258 144 194
2021/20222.114 141 188 156 189 194 119 178 158 187 193 248 163
2022/20231.653 148 144 60 123 143 272 130 152 182 88 93 118
2023/20241.648 135 146 155 160 189 153 125 159 57 97 148 124
2024/20251.216 134 142 159 183 380 213 5 0 0 0 0 0
Totale 11.034